Aktie VIVANZA6 VIVANZA BIOSCIENCES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Vivanza Biosciences Limited

Aktien

VIVANZA6

INE984E01035

VIVANZA6

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:00:51 10.05.2024 		% 5 Tage % 1. Jan.
6.55 INR -1.50% Intraday Chart für Vivanza Biosciences Limited -14.38% -39.18%
30.04. Vivanza Biosciences Limited gibt den Rücktritt von Direktoren bekannt CI
30.04. Vivanza Biosciences Limited berichtet über die Ergebnisse für das am 31. März 2024 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Vivanza Biosciences Limited Announces Directors Resignation
Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Vivanza Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Vivanza Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Vivanza Biosciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Vivanza Biosciences Limited Announces Resignation of Manali S. Patel as Independent Director
Vivanza Biosciences Limited Announces Resignation of Girish Bhatt as Managing Director
Vivanza Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Vivanza Biosciences Bags Contract to Set Up Pharmaceutical Packaging Facility in Sudan
Vivanza Biosciences Limited Announces Receipt of Work Orders Worth Approximately USD 1 Million in Institutional and Industrial Categories
Vivanza Biosciences Shelves Planned Preferential Share Allotment
Vivanza Biosciences Limited cancelled the transaction announced on July 21, 2022
Vivanza Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Vivanza Biosciences Limited announced a financing transaction
Vivanza Biosciences Limited Appoints Avinash G. Bhojwani as Company Secretary and Compliance Officer
Vivanza Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
Vivanza Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
Vivanza Biosciences Limited Announces Change of Designation of Girish Bhatt to Non Executive Director
Vivanza Biosciences Limited Announces Appointment of Hemant Parikh as Chief Executive Officer
Vivanza Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. VIVANZA6 Aktie
  4. Nachrichten Vivanza Biosciences Limited
  5. Andere Sprachen